Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 1.14% | 67.56 | 1.0% | $1024.31m | |
| BIIB | Biogen, Inc. | -0.37% | 333.00 | 1.5% | $704.38m | |
| AMGN | Amgen, Inc. | 0.20% | 223.48 | 1.3% | $582.04m | |
| ILMN | Illumina, Inc. | 2.59% | 298.92 | 3.5% | $424.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.19% | 399.55 | 2.6% | $378.07m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.55% | 243.82 | 1.9% | $358.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.83% | 102.56 | 2.0% | $204.52m | |
| EXAS | EXACT Sciences Corp. | 3.61% | 98.18 | 24.0% | $177.12m | |
| A | Agilent Technologies, Inc. | 0.43% | 85.84 | 1.6% | $157.99m | |
| SGEN | Seattle Genetics, Inc. | -0.13% | 118.07 | 6.1% | $115.03m | |
| MRNA | Moderna, Inc. | -0.24% | 19.00 | 0.0% | $108.13m | |
| INCY | Incyte Corp. | 0.51% | 78.45 | 2.5% | $101.70m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.31% | 125.42 | 14.6% | $97.52m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.87% | 89.01 | 4.3% | $96.71m | |
| XLRN | Acceleron Pharma, Inc. | -0.48% | 93.66 | 6.1% | $94.41m |
Company Profile
Miragen Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product pipelines include MRG-106 that focuses on the treatment of blood cancer; and MRG-201 deals with the treatment of pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Boulder, CO.